Skip to main content
SpringerLink
Log in

Recent changes in demographics and outcomes of cervical cancer in the United States

  • News and Views
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Data availability

The data on which this study is based are publicly available upon request at http://seer.cancer.gov/.

References

  1. Arbyn M, Weiderpass E, Bruni L et al (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8(2):e191–e203

    Article  Google Scholar 

  2. Ginsburg O, Bray F, Coleman MP et al (2017) The global burden of women’s cancers: a grand challenge in global health. Lancet 389(10071):847–860

    Article  Google Scholar 

  3. Siegel RL, Miller KD, Fuchs HE, Jemal A (2021) Cancer statistics, 2021. CA Cancer J Clin 71(1):7–33

    Article  Google Scholar 

  4. Rare cancer. NIH National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-cancer. Accessed 25 Apr 2021

  5. Cancer stat facts: cervical cancer. NIH National Cancer Institute Surveillance, Epidemiology, and End Results Program. https://seer.cancer.gov/statfacts/html/cervix.html. Accessed 25 Apr 2021

  6. National Cancer Institute's, The Surveillance, Epidemiology, and End Results (SEER) Program, http://seer.cancer.gov/. Accessed 25 Apr 2021

  7. Hoffman MS, Chi DS, Clarke-Pearson DL, Cliby W, Creasman W, Underwood PB Jr (2020) Surgical training in gynecologic oncology: past, present, future. Gynecol Oncol 158:188–193

    Article  Google Scholar 

Download references

Funding

Ensign Endowment for Gynecologic Cancer Research (K.M.). The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author information

Authors and Affiliations

  1. Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Southern California, 2020 Zonal Avenue, IRD 520, Los Angeles, CA, 90033, USA

    Koji Matsuo, Erica J. Chang, Shinya Matsuzaki, Marcia A. Ciccone & Lynda D. Roman

  2. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA

    Koji Matsuo & Lynda D. Roman

  3. Department of Obstetrics and Gynecology, Tohoku University School of Medicine, Miyagi, Japan

    Muneaki Shimada

Authors
  1. Koji Matsuo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erica J. Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinya Matsuzaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Muneaki Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Marcia A. Ciccone
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lynda D. Roman
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

KM: conceptualization, funding acquisition, investigation, methodology, analysis, project administration, supervision, validation, writing (original draft); EJC: investigation, reviewing and editing; SM: literature review, investigation, and reviewing and editing; MS: investigation, reviewing and editing; MAC: investigation, reviewing and editing; LDR: supervision, funding acquisition, reviewing and editing.

Corresponding author

Correspondence to Koji Matsuo.

Ethics declarations

Conflict of interest

The followings are outside this work: consultant, Quantgene (LDR); honorarium, Chugai (KM); research grant, Merck (SM); none for others.

Ethical approval

University of Southern California (HS-16-00481).

Disclaimer

The manuscript’s corresponding author (KM) affirms that the manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained. The Surveillance, Epidemiology, and End Results Program was operated by the National Cancer Institute, and the program is the source of the de-identified data used; and the program has not verified and is not responsible for the statistical validity of the data analysis or the conclusions derived by the study team. The National Cancer Institute Surveillance, Epidemiology, and End Results Program classified the race/ethnicity, and the current study used the default grouping for analysis.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuo, K., Chang, E.J., Matsuzaki, S. et al. Recent changes in demographics and outcomes of cervical cancer in the United States. Arch Gynecol Obstet 304, 1–3 (2021). https://doi.org/10.1007/s00404-021-06092-w

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-021-06092-w

Search

Navigation